Murine models of Chlamydia pneumoniae infection and atherosclerosis

被引:181
|
作者
Moazed, TC
Kuo, CC
Grayston, JT
Campbell, LA
机构
[1] UNIV WASHINGTON,DEPT PATHOBIOL,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195
来源
JOURNAL OF INFECTIOUS DISEASES | 1997年 / 175卷 / 04期
关键词
D O I
10.1086/513986
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia pneumoniae have been demonstrated in atherosclerotic lesions but not in normal arteries. An animal model of both C, pneumoniae and atherosclerosis is needed to investigate the role of the organism in atherosclerosis. Apolipoprotein (apo) E-deficient transgenic mice, which spontaneously develop atherosclerosis, and C57BL/6J mice, which only develop atherosclerosis on an atherogenic diet, were evaluated. Following single and multiple intranasal inoculations of apoE-deficient transgenic mice, C. pneumoniae were detected in lung, aorta, and spleen for 20 weeks after inoculation in 25%-100% of mice, In the aorta, C. pneumoniae were detected within the atherosclerotic lesion. In C57BL/6J mice on a nonatherogenic diet, C. pneumoniae were detected in the aorta only 2 weeks after a single intranasal inoculation in 8% of mice, The persistence of C. pneumoniae in atheromas suggests a tropism of C. pneumoniae to the lesion. These mouse models should be useful for studying the pathogenic role of C. pneumoniae in atherosclerosis.
引用
收藏
页码:883 / 890
页数:8
相关论文
共 50 条
  • [31] Chlamydia pneumoniae and atherosclerosis
    Belland, RJ
    Ouellette, SP
    Gieffers, J
    Byrne, GI
    CELLULAR MICROBIOLOGY, 2004, 6 (02) : 117 - 127
  • [32] Experimental rabbit models of Chlamydia pneumoniae infection
    Moazed, TC
    Kuo, CC
    Patton, DL
    Grayston, JT
    Campbell, LA
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (02): : 667 - 676
  • [33] Chlamydia pneumoniae infection - An association with atherosclerosis in hemodialysis patients.
    Wszola, M
    Kwiatkowski, A
    Nosek, R
    Podsiadly, E
    Meszaros, J
    Danielewicz, R
    Ostrowski, K
    Chmura, A
    Adadynski, L
    Fesolowicz, S
    Paczek, L
    Durlik, M
    Tylewska-Wierzbanowska, S
    Rowinski, W
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 382 - 383
  • [34] Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus:: Weighing the evidence
    High, KP
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) : 746 - 749
  • [35] Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice
    Caligiuri, G
    Rottenberg, M
    Nicoletti, A
    Wigzell, H
    Hansson, GK
    CIRCULATION, 2001, 103 (23) : 2834 - 2838
  • [36] Chlamydia pneumoniae infection in diabetic and nondiabetic patients with severe atherosclerosis
    Tiran, A
    Stanger, O
    Trinker, M
    Tiesenhausen, K
    Schmidt, R
    Tiran, B
    DIABETOLOGIA, 2000, 43 : A268 - A268
  • [37] Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
    Ericson, K
    Saldeen, TGP
    Lindquist, O
    Påhlson, C
    Mehta, JL
    CIRCULATION, 2000, 101 (22) : 2568 - 2571
  • [38] Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
    Leinonen, M
    Saikku, P
    AMERICAN HEART JOURNAL, 1999, 138 (05) : S504 - S506
  • [39] Chlamydia pneumoniae infections in mouse models:: relevance for atherosclerosis research
    de Kruif, MD
    van Gorp, ECM
    Keller, TT
    Ossewaarde, JM
    ten Cate, H
    CARDIOVASCULAR RESEARCH, 2005, 65 (02) : 317 - 327
  • [40] Value of animal models for Chlamydia pneumoniae-related atherosclerosis
    Fong, IW
    AMERICAN HEART JOURNAL, 1999, 138 (05) : S512 - S513